Metabolomics in cancer and cancer-associated inflammatory cells

Abstract

Metabolomics is the last frontier of modern molecular biology, and the state-of-the-art technique for studying metabolism. Mass spectrometry and nuclear magnetic resonance spectroscopy are the main analytical approaches in metabolomics. Cellular metabolism plays a pivotal role during cell resting and activation. Immune cells exhibit remarkable metabolic plasticity, fundamental to support their adaptation to inflammatory environments and functional requirements. Cancer is a metabolic and inflammatory disease. A metabolic shift is crucial for oncogenesis, tumor cell survival, invasion, metastasis, and the associated inflammatory process. The tumor microenvironment is mainly orchestrated by immune-inflammatory cells and essential for the neoplastic process. Inflammatory cells from tumor stroma adapt to different metabolic pathways during tumor progression, and this metabolic reprogramming affects macrophages, neutrophils, T cells, and others. Targeting the metabolism of tumor and immune cells may lead to important therapeutic implications in cancer. Thus, understanding the metabolic changes that drive the interactions between tumor and stromal cells is a promising avenue advances in cancer diagnostics and therapies, leading to more accurate guidance. In this review, we discuss the most recent metabolomics approaches in cancer studies on the tumor-associated inflammatory microenvironment.

Keywords

Metabolomics / cancer / immunometabolism / inflammation

References

[1] Honigmann JJ.The human frontier. By Roger J. Williams. Harcourt Brace and Co., New York, viii + 314 pp., references, index, 1946. ($3.00)..Am J Phys Anthropol1947;5:378-9

[2] Gates SC,Krivit W,Blaisdell BE.Automated metabolic profiling of organic acids in human urine. II. Analysis of urine samples from “healthy” adults, sick children, and children with neuroblastoma..Clin Chem1978;24:1680-9

[3] Oliver SG,Kell DB.Systematic functional analysis of the yeast genome..Trends Biotechnol1998;16:373-8

[4] Wu H,Hines A.High-throughput tissue extraction protocol for NMR- and MS-based metabolomics..Anal Biochem2008;372:204-12

[5] Markley JL,Edison AS.The future of NMR-based metabolomics..Curr Opin Biotechnol2017;43:34-40 PMCID:PMC5305426

[6] Mathew AK.Metabolomics: the apogee of the omics trilogy..Int J Pharm Pharm Sci2013;5:45-48

[7] Halama A,Pasquier J.Metabolic signatures differentiate ovarian from colon cancer cell lines..J Transl Med2015;13:223 PMCID:PMC4499939

[8] Nicholson JK.Global systems biology, personalized medicine and molecular epidemiology..Mol Syst Biol2006;2:52 PMCID:PMC1682018

[9] Fukui Y.A plasma metabolomic investigation of colorectal cancer patients by liquid chromatography-mass spectrometry..Open Anal Chem J2010;4:1-9 PMCID:PMC7216900

[10] Odunsi K,Ambrosone CB.Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics..Int J Cancer2005;113:782-8

[11] Ben Sellem D,Neuville A.Metabolomic characterization of ovarian epithelial carcinomas by HRMAS-NMR spectroscopy..J Oncol2011;2011:174019 PMCID:PMC3090613

[12] Qiu YP,Zhou BS.A distinct metabolic signature of human colorectal cancer with prognostic potential..Clin Cancer Res2014;20:2136-46 PMCID:PMC5902798

[13] Haas R,Rocher-Ros V.Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions..PLoS Biol2015;13:e1002202 PMCID:PMC4504715

[14] Cuperlović-Culf M,Culf AS.Cell culture metabolomics: applications and future directions..Drug Discov Today2010;15:610-21

[15] Iorio E,Alberti P.Alterations of choline phospholipid metabolism in ovarian tumor progression..Cancer Res2005;65:9369-76

[16] Warburg O.Versuche an Überlebendem carcinom-gewebe..Klin Wochenschr1923;2:776-7

[17] Warburg O,Posener K.Versuche an Überlebendem carcinomgewebe..Klin Wochenschr1924;3:1062-4

[18] Warburg O.The metabolism of carcinoma cells..J Cancer Res1925;9:148-63

[19] Warburg O,Negelein E.The metabolism of tumors in the body..J Gen Physiol1927;8:519-30 PMCID:PMC2140820

[20] DeBerardinis RJ,Daikhin E.Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis..Proc Natl Acad Sci U S A2007;104:19345-50 PMCID:PMC2148292

[21] Lafita-Navarro MC,Zacharias LG,DeBerardinis RJ.The transcription factors aryl hydrocarbon receptor and MYC cooperate in the regulation of cellular metabolism..J Biol Chem2020;295:12398-407 PMCID:PMC7458811

[22] Rodrigues MF,de Melo FH.Enhanced OXPHOS, glutaminolysis and β-oxidation constitute the metastatic phenotype of melanoma cells..Biochem J2016;473:703-15

[23] LeBleu VS,Gonzalez Herrera KN.PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis..Nat Cell Biol2014;16:992-10031-15 PMCID:PMC4369153

[24] Jitschin R,Bruns H.Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia..Blood2014;123:2663-72

[25] Bonuccelli G,Whitaker-Menezes D.Ketones and lactate “fuel” tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism..Cell Cycle2010;9:3506-14 PMCID:PMC3047616

[26] Ippolito L,Cavallini L.Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells..Oncotarget2016;7:61890-904 PMCID:PMC5308698

[27] Denise C,Calvani M.5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits..Oncotarget2015;6:41706-21 PMCID:PMC4747183

[28] Caro P,Norberg E.Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma..Cancer Cell2012;22:547-60 PMCID:PMC3479446

[29] Labbé DP,Yang M.High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program..Nat Commun2019;10:4358 PMCID:PMC6761092

[30] Stenman K,Gröbner G,Bergh A.Detection of polyunsaturated omega-6 fatty acid in human malignant prostate tissue by 1D and 2D high-resolution magic angle spinning NMR spectroscopy..MAGMA2009;22:327-31

[31] Kurhanewicz J,Nelson SJ.Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy..Urology1995;45:459-66

[32] Lynch MJ.Proton MRS of human prostatic fluid: correlations between citrate, spermine, andmyo-inositol levels and changes with disease..Prostate1997;30:248-55

[33] Van Der Graaf M,Oosterhof GON,Verhofstad AAJ.Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer..MAGMA2000;10:153-9

[34] Serkova NJ,Jones RH.The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions..Prostate2008;68:620-8

[35] Thysell E,Hörnberg E.Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol..PLoS One2010;5:e14175 PMCID:PMC2997052

[36] Schwab A,Vazakidou ME.Polyol pathway links glucose metabolism to the aggressiveness of cancer cells..Cancer Res2018;78:1604-18

[37] Ferretti A,Knijn A.Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a(1)H NMR study..Br J Cancer2002;86:1180-7 PMCID:PMC2364195

[38] Xu J,Lee HJ.Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma..Elife2019;8:e38986 PMCID:PMC6459676

[39] Lucarelli G,Rutigliano M.Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma..Oncotarget2015;6:13371-86 PMCID:PMC4537021

[40] Lu X,Mu E,Kang YB.Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model..J Biol Chem2010;285:9317-21 PMCID:PMC2843179

[41] Hart CD,Luchinat C.Stearns V.Metabolomics in breast cancer: current status and perspectives..Novel biomarkers in the continuum of breast cancer.2016;ChamSpringer International Publishing217-34

[42] Semenza GL.Regulation of metabolism by hypoxia-inducible factor 1..Cold Spring Harb Symp Quant Biol2011;76:347-53

[43] Pecqueur C,Oizel K,Vallette FM.Targeting metabolism to induce cell death in cancer cells and cancer stem cells..Int J Cell Biol2013;2013:805975 PMCID:PMC3583110

[44] Warburg O.On the origin of cancer cells..Science1956;123:309-14

[45] Gatenby RA.Why do cancers have high aerobic glycolysis?.Nat Rev Cancer2004;4:891-9

[46] Deberardinis RJ,Ditsworth D.Brick by brick: metabolism and tumor cell growth..Curr Opin Genet Dev2008;18:54-61 PMCID:PMC2476215

[47] Estrela JM,Obrador E.Glutathione in cancer biology and therapy..Crit Rev Clin Lab Sci2006;43:143-81

[48] Kim MH.Oncogenes and tumor suppressors regulate glutamine metabolism in cancer cells..J Cancer Prev2013;18:221-6 PMCID:PMC4189465

[49] Egeblad M,Werb Z.Tumors as organs: complex tissues that interface with the entire organism..Dev Cell2010;18:884-901 PMCID:PMC2905377

[50] Nagy C.Time and demand are two critical dimensions of immunometabolism: the process of macrophage activation and the pentose phosphate pathway..Front Immunol2015;6:164 PMCID:PMC4389563

[51] Hu C,Zhao HL.A biochemical comparison of the lung, colonic, brain, renal, and ovarian cancer cell lines using 1H-NMR spectroscopy..Biosci Rep2020;40:BSR20194027 PMCID:PMC7198042

[52] Budczies J,Györffy B.Glutamate enrichment as new diagnostic opportunity in breast cancer..Int J Cancer2015;136:1619-28

[53] Willmann L,Halbach S,Stickeler E.Metabolic profiling of breast cancer: differences in central metabolism between subtypes of breast cancer cell lines..J Chromatogr B Analyt Technol Biomed Life Sci2015;1000:95-104

[54] Oakman C,Claudino WM.Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods..Ann Oncol2011;22:1295-301

[55] Jobard E,Blaise BJ,Elena-Herrmann B.A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer..Cancer Lett2014;343:33-41

[56] Tenori L,Claudino WM.Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study..Mol Oncol2012;6:437-44 PMCID:PMC5528357

[57] Asiago VM,Shanaiah N.Early detection of recurrent breast cancer using metabolite profiling..Cancer Res2010;70:8309-18 PMCID:PMC2995269

[58] Shi XL,Huang F,Morrison SJ.The abundance of metabolites related to protein methylation correlates with the metastatic capacity of human melanoma xenografts..Sci Adv2017;3:eaao5268 PMCID:PMC5665593

[59] Cierlitza M,Bogeski I.Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations..Exp Dermatol2015;24:155-7 PMCID:PMC4335723

[60] Shu SL,Allen CL.Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment..Sci Rep2018;8:12905 PMCID:PMC6110845

[61] Fedele TA,Jose de Farias e Melo H,Maria DA.Prognostic relationship of metabolic profile obtained of melanoma B16F10..Biomed Pharmacother2013;67:146-56

[62] Mears R,Hanrahan S.Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry..Proteomics2004;4:4019-31

[63] Martinez-Outschoorn UE,Howell A.Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment..Int J Biochem Cell Biol2011;43:1045-51 PMCID:PMC3102770

[64] Colegio OR,Szabo AL.Functional polarization of tumour-associated macrophages by tumour-derived lactic acid..Nature2014;513:559-63 PMCID:PMC4301845

[65] Fridlender ZG,Kim S.Polarization of tumor-associated neutrophil phenotype by TGF-β: “N1” versus “N2” TAN..Cancer Cell.2009;16:183-94 PMCID:PMC2754404

[66] Ohta A,Prasad SJ.A2A adenosine receptor protects tumors from antitumor T cells..Proc Natl Acad Sci U S A2006;103:13132-7 PMCID:PMC1559765

[67] Fiaschi T,Giannoni E.Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay..Cancer Res2012;72:5130-40

[68] Choi SY,Gout PW.Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?.J Pathol2013;230:350-5 PMCID:PMC3757307

[69] Brand A,Koehl GE.LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells..Cell Metab2016;24:657-71

[70] Chang CH,O’Sullivan D.Metabolic competition in the tumor microenvironment is a driver of cancer progression..Cell2015;162:1229-41 PMCID:PMC4864363

[71] Lyssiotis CA.Metabolic interactions in the tumor microenvironment..Trends Cell Biol2017;27:863-75 PMCID:PMC5814137

[72] Griffiths JR.Are cancer cells acidic?.Br J Cancer1991;64:425-7 PMCID:PMC1977628

[73] Wike-hooley J,Reinhold H.The relevance of tumour pH to the treatment of malignant disease..Radiother Oncol1984;2:343-66

[74] Reina-Campos M,Diaz-Meco M.Metabolism shapes the tumor microenvironment..Curr Opin Cell Biol2017;48:47-53 PMCID:PMC5650101

[75] Pavlova NN.The emerging hallmarks of cancer metabolism..Cell Metab2016;23:27-47 PMCID:PMC4715268

[76] Hanahan D.Hallmarks of cancer: the next generation..Cell2011;144:646-74

[77] Hensley CT,Yuan Q.Metabolic heterogeneity in human lung tumors..Cell2016;164:681-94 PMCID:PMC4752889

[78] Kalluri R.The biology and function of fibroblasts in cancer..Nat Rev Cancer2016;16:582-98

[79] Ward PS.Metabolic reprogramming: a cancer hallmark even warburg did not anticipate..Cancer Cell2012;21:297-308 PMCID:PMC3311998

[80] Heiden MGV,Thompson CB.Understanding the Warburg effect: the metabolic requirements of cell proliferation..Science2009;324:1029-33 PMCID:PMC2849637

[81] Yang L,Yeung TL.Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth..Cell Metab2016;24:685-700 PMCID:PMC7329194

[82] Zhao HY,Baddour J.Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism..Elife2016;5:e10250 PMCID:PMC4841778

[83] Zhang DX,Shi ZM.Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation..Cell Rep2015;10:1335-48

[84] Pavlides S,Castello-Cros R.The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma..Cell Cycle2009;8:3984-4001

[85] Sotgia F,Howell A,Pavlides S.Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms..Annu Rev Pathol2012;7:423-67

[86] Sousa CM,Wang X.Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion..Nature2016;536:479-83 PMCID:PMC5228623

[87] Wang WM,Dostál L.Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer..Cell2016;165:1092-105 PMCID:PMC4874853

[88] Munn DH,Attwood JT,Pashine A.Inhibition of T cell proliferation by macrophage tryptophan catabolism..J Exp Med1999;189:1363-72 PMCID:PMC2193062

[89] Munn DH,Baban B.GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase..Immunity2005;22:633-42

[90] Platten M,Van den Eynde BJ.Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion..Cancer Res2012;72:5435-40

[91] Fletcher M,Sierra RA.l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells..Cancer Res2015;75:275-83 PMCID:PMC4297565

[92] Al-Sarireh B.Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth..J R Coll Surg Edinb2000;45:1-16

[93] Deng L,Sellers RS.A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis..Am J Pathol2010;176:952-67 PMCID:PMC2808099

[94] Sica A,Mantovani A.Tumor-associated macrophages: a molecular perspective..Int Immunopharmacol2002;2:1045-54

[95] Heller DS,Cracchiolo B.Presence and quantification of macrophages in squamous cell carcinoma of the cervix..Int J Gynecol Cancer2003;13:67-70

[96] Murray PJ,Biswas SK.Macrophage activation and polarization: nomenclature and experimental guidelines..Immunity2014;41:14-20 PMCID:PMC4123412

[97] Langston PK,Horng T.Metabolism supports macrophage activation..Front Immunol2017;8:61 PMCID:PMC5281575

[98] Rodríguez-Prados JC,Cuenca J.Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation..J Immunol2010;185:605-14

[99] Jha AK,Sergushichev A.Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization..Immunity2015;42:419-30

[100] Van den Bossche J,Menon D.Macrophage immunometabolism: where are we (going)?.Trends Immunol2017;38:395-406

[101] Haschemi A,Gille L.The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism..Cell Metab2012;15:813-26 PMCID:PMC3370649

[102] Fuchs AL,Keegan WJ.Quantitative ¹H NMR metabolomics reveal distinct metabolic adaptations in human macrophages following differential activation..Metabolites2019;9:248 PMCID:PMC6918149

[103] O’Neill LA,Rathmell J.A guide to immunometabolism for immunologists..Nat Rev Immunol2016;16:553-65 PMCID:PMC5001910

[104] Covarrubias AJ,Horng T.Control of macrophage metabolism and activation by mTOR and Akt signaling..Semin Immunol2015;27:286-96 PMCID:PMC4682888

[105] Festuccia WT,Bakan I,Laplante M.Myeloid-specific Rictor deletion induces M1 macrophage polarization and potentiates in vivo pro-inflammatory response to lipopolysaccharide..PLoS One2014;9:e95432 PMCID:PMC3989321

[106] de-Brito NM,da-Costa H.Aerobic glycolysis is a metabolic requirement to maintain the M2-like polarization of tumor-associated macrophages..Biochim Biophys Acta Mol Cell Res2020;1867:118604

[107] Arts RJW,Tuit S.Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages..Oncoimmunology2016;5:e1229725 PMCID:PMC5213309

[108] Liu D,Lu N.Comprehensive proteomics analysis reveals metabolic reprogramming of tumor-associated macrophages stimulated by the tumor microenvironment..J Proteome Res2017;16:288-97

[109] Poczobutt JM,Yadav VK.Expression profiling of macrophages reveals multiple populations with distinct biological roles in an immunocompetent orthotopic model of lung cancer..J Immunol2016;196:2847-59 PMCID:PMC4779748

[110] Mestas J.Of mice and not men: differences between mouse and human immunology..J Immunol2004;172:2731-8

[111] Ley K, Hoffman HM, Kubes P, et al. Neutrophils: new insights and open questions. Vol 3.; 2018. Available from: http://immunology.sciencemag.org/. [Last accessed on 24 Dec 2020]

[112] Mantovani A,Costantini C.Neutrophils in the activation and regulation of innate and adaptive immunity..Nat Rev Immunol2011;11:519-31

[113] Kolaczkowska E.Neutrophil recruitment and function in health and inflammation..Nat Rev Immunol2013;13:159-75

[114] Howard R,Egan KM.Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer..Sci Rep2019;9:19673

[115] Masucci MT,Carriero MV.Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy..Front Oncol2019;9:1146 PMCID:PMC6874146

[116] Fridlender ZG.Tumor-associated neutrophils: friend or foe?.Carcinogenesis2012;33:949-55

[117] Sun R,Li D.Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells..Oncotarget2014;5:12621-34 PMCID:PMC4350330

[118] Meyer PALGM. THE ACTION OF LETJCOCYTES ON GLUCOSE. J Biol Chem 1912;11:361-70. Available from: https://www.jbc.org/content/11/4/361.short. [Last accessed on 24 Dec 2020]

[119] Maianski NA,Srinivasula SM,Roos D.Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis..Cell Death Differ2004;11:143-53

[120] Maratou E,Kollias A.Glucose transporter expression on the plasma membrane of resting and activated white blood cells..Eur J Clin Invest2007;37:282-90

[121] Zanoni I,Broggi A,Kumar S.Metabolic insight of neutrophils in health and disease..Front Immunol2019;10:2099 PMCID:PMC6764236

[122] Simpson IA,Malide D.The facilitative glucose transporter GLUT3: 20 years of distinction..Am J Physiol Endocrinol Metab2008;295:E242-53 PMCID:PMC2519757

[123] Loftus RM.Immunometabolism: cellular metabolism turns immune regulator..J Biol Chem2016;291:1-10 PMCID:PMC4697146

[124] Borregaard N.Energy metabolism of human neutrophils during phagocytosis..J Clin Invest1982;70:550-7 PMCID:PMC370256

[125] van Raam BJ,de Wit E,Verhoeven AJ.Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation..PLoS One2008;3:e2013 PMCID:PMC2295260

[126] Chokesuwattanaskul S,Edwards SW.A robust intracellular metabolite extraction protocol for human neutrophil metabolic profiling..PLoS One2018;13:e0209270 PMCID:PMC6301625

[127] Ching-Cheng Huang S,Ivanova Y.Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages..Nat Immunol2014;15:846-55 PMCID:PMC4139419

[128] Rice CM,Subleski JJ.Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression..Nat Commun2018;9:5099 PMCID:PMC6269473

[129] Veglia F,Blasi M.Fatty acid transport protein 2 reprograms neutrophils in cancer..Nature2019;569:73-8 PMCID:PMC6557120

[130] Hsu BE,Johnson RM.Immature low-density neutrophils exhibit metabolic flexibility that facilitates breast cancer liver metastasis..Cell Rep2019;27:3902-15

[131] Jing C,Richoz N.Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis..Proc Natl Acad Sci U S A2020;117:15160-71 PMCID:PMC7334513

[132] Don AS.Recent clinical trials of mTOR-targeted cancer therapies..Rev Recent Clin Trials2011;6:24-35

[133] Halbrook CJ,Kovalenko I.Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer..Cell Metab2019;29:1390-9 PMCID:PMC6602533

[134] Ouimet M,Gundra UM.MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis..J Clin Invest2015;125:4334-48 PMCID:PMC4665799

[135] Wenes M,Di Matteo M.Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis..Cell Metab2016;24:701-15

[136] Simões RL,Cunha-Costa H.Lipoxin A₄ selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression..Int J Cancer2017;140:346-57

[137] de-Brito NM,Simões RL.Lipoxin-induced phenotypic changes in CD115⁺LY6C^hi monocytes TAM precursors inhibits tumor development..Front Oncol2019;9:540 PMCID:PMC6593314

[138] Erika Palmieri AM,Martín-Pérez R,Mazzone M.Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis..Cell Rep2017;20:1654-66 PMCID:PMC5575233

[139] Weiss JM,Karwan M.Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors..J Clin Invest2018;128:3794-805 PMCID:PMC6118601

[140] Ligibel JA,Courneya KS.American Society of Clinical Oncology position statement on obesity and cancer..J Clin Oncol2014;32:3568-74 PMCID:PMC4979237

[141] Lauby-Secretan B,Loomis D,Bianchini F.Body fatness and cancer--viewpoint of the IARC working group..N Engl J Med2016;375:794-8 PMCID:PMC6754861

[142] Quail DF.The obese adipose tissue microenvironment in cancer development and progression..Nat Rev Endocrinol2019;15:139-54 PMCID:PMC6374176

[143] Moore T,Carbajal S.Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues..Cancer Prev Res (Phila)2008;1:65-76

[144] Jiang WQ,Thompson HJ.Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver..Cancer Res2008;68:5492-9 PMCID:PMC2587286

[145] Iyengar NM,Zhou XK.Metabolic obesity, adipose inflammation and elevated breast aromatase in women with normal body mass index..Cancer Prev Res (Phila)2017;10:235-43 PMCID:PMC5380584

[146] Carter JM,Pena MA.Macrophagic “Crown-like Structures” are associated with an increased risk of breast cancer in benign breast disease..Cancer Prev Res (Phila)2018;11:113-9 PMCID:PMC7465518

[147] Koru-Sengul T,Miao F.Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians..Breast Cancer Res Treat2016;158:113-26 PMCID:PMC5129629

[148] Gucalp A,Zhou XK.Periprostatic adipose inflammation is associated with high-grade prostate cancer..Prostate Cancer Prostatic Dis2017;20:418-23 PMCID:PMC5681425

[149] Franklin RA,Sarkar A.The cellular and molecular origin of tumor-associated macrophages..Science2014;344:921-5 PMCID:PMC4204732

[150] Edmunds LR,Kang A.c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate..J Biol Chem2014;289:25382-92 PMCID:PMC4155699

[151] Lyssiotis CA,Cantley LC.Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance..Cell Cycle2013;12:1987-8 PMCID:PMC3737294

[152] Son J,Ying HQ.Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway..Nature2013;496:101-5

[153] Meyer KA,Baker NA.Adipocytes promote pancreatic cancer cell proliferation via glutamine transfer..Biochem Biophys Rep2016;7:144-9

[154] Incio J,Suboj P.Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy..Cancer Discov2016;6:852-69 PMCID:PMC4972679

[155] Rizi BS,Nowicka A.Nitric oxide mediates metabolic coupling of omentum-derived adipose stroma to ovarian and endometrial cancer cells..Cancer Res.2015;75:456-71

[156] Nieman KM,Penicka CV.Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth..Nat Med2011;17:1498-503 PMCID:PMC4157349

[157] Balaban S,Lee LS.Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration..Cancer Metab2017;5:1

[158] Loo TM,Watanabe Y.Gut microbiota promotes obesity-associated liver cancer through PGE₂-mediated suppression of antitumor immunity..Cancer Discov2017;7:522-38

[159] Piotto M,Imperiale A.Lutz N,Wevers R.Reproducible sample preparation and spectrum acquisition techniques for metabolic profiling of human tissues by proton high-resolution magic angle spinning nuclear magnetic resonance..Methodologies for metabolomics.2012;CambridgeCambridge University Press496-524

[160] Chan EC,Mal M.Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS)..J Proteome Res2009;8:352-61

[161] Mirnezami R,Li JV.Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies..Ann Surg2014;259:1138-49

[162] Sitter B,Bathen TF,Fjosne HE.Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters..NMR Biomed2006;19:30-40

[163] Li ML,Cho N.An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy..PLoS One2011;6:e25563 PMCID:PMC3196497

[164] Tripathi P,Ponnusamy M.HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease..J Proteome Res2013;12:3519-28 PMCID:PMC3722911

[165] Righi V,Valentini A.A metabolomic data fusion approach to support gliomas grading..NMR Biomed2020;33:e4234

[166] Wishart DS.Emerging applications of metabolomics in drug discovery and precision medicine..Nat Rev Drug Discov2016;15:473-84

[167] Beger RD,Schmidt MA.Metabolomics enables precision medicine: “A White Paper, Community Perspective”..Metabolomics2016;12:149 PMCID:PMC5009152

[168] Yu L,Zhang XY.Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review..Oncotarget2017;8:115774-86 PMCID:PMC5777812

[169] Choi J,Yakubov E,Regnier-Vigouroux A.Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages..Cancer Biol Ther2015;16:1205-13 PMCID:PMC4623498